BSE filing, BSE: 544191. Summary written from the filing by ALFA Finder's alert engine.
Purple Finance Ltd: key numbers
- Share price
- ₹63.42
- Market cap
- ₹489.2 Cr
- Revenue (annual)
- ₹47.65 Cr
- Net profit (annual)
- ₹-6.44 Cr
- P/E (TTM)
- -198.1×Sector 19.7×
- Promoter holding
- 35.56%+11.10% QoQ
- FII holding
- 0.65%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Purple Finance Ltd
All →Purple Finance Debt & Borrowing: ₹0.16 Cr
Purple Finance paid Rs 16.44 lakh interest on its secured NCDs on the due date, October 26, 2026. TDS was deducted as per applicable law.
- Value
- ₹0.16 Cr
Purple Finance Business Update
Purple Finance plans to enter affordable housing finance and launched two new MSME-focused lending products, while sharing operational performance updates and financial highlights.
Purple Finance Q2 FY27 Results: Turns Profitable, Net Profit ₹1 Cr
Purple Finance Ltd reported revenue from operations of ₹17.3 Cr (+55.9% YoY) and net profit of ₹1 Cr for Q2 FY27.
- Key figure
- Net profit ₹1 Cr
Purple Finance Employee Stock Options
Purple Finance allotted 5,000 equity shares to employees upon ESOP exercise at Rs. 33 per share. Paid-up capital increased to 7.71 crore shares.
Purple Finance Debt & Borrowing: ₹0.17 Cr
Purple Finance Ltd successfully paid Rs.0.17 Crore as interest on its non-convertible debentures for the period ending October 2026.
- Value
- ₹0.17 Cr
Purple Finance Debt & Borrowing: ₹0.2 Cr
Purple Finance paid Rs. 0.1956 Crore interest on non-convertible debentures for the period ending October 5, 2026.
- Value
- ₹0.20 Cr
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.